Author:
Michel Lars,Rassaf Tienush
Funder
IFORES research grant, Medical Faculty, University Duisburg-Essen, Germany
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Heron M. Deaths: leading causes for 2016. Natl Vital Stat Rep. 2018;67:1–77.
2. Institute NC. Annual report to the nation on the status of cancer. In: Surveillance, epidemiology, and end results program. 2018.
https://seer.cancer.gov/statfacts/
.
3. Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the “Silver Tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers Prev. 2016;25:1029–36.
4. Zamorano JL, Lancellotti P, Rodriguez Munoz D, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:2768–801.
5. Chang HM, Moudgil R, Scarabelli T, et al. Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1. J Am Coll Cardiol. 2017;70:2536–51.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献